The Association between Patient Activation and Outcomes among Severely Mentally Ill Patients.
Journal
The journal of behavioral health services & research
ISSN: 1556-3308
Titre abrégé: J Behav Health Serv Res
Pays: United States
ID NLM: 9803531
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
pubmed:
19
11
2020
medline:
26
10
2021
entrez:
18
11
2020
Statut:
ppublish
Résumé
Little is known about the association between patient activation, health, service utilization, and cost among mental health (MH) patients. Patients aged 18 to 64 with schizophrenia (Sz, n = 43), bipolar disorder (BD, n = 59), or major depressive disorder (MDD, n = 34) completed the Patient Activation Measure for Mental Health (PAM-MH), the Colorado Symptom Index, demographic, socioeconomic, treatment, and social support questionnaire items. Average PAM-MH score indicated BD patients the most activated (66.6 ± 17.5), Sz (57.4 ± 10.4) less activated, and MDD the least activated (55.4 ± 14.6). The MDD cohort had the highest ($27,616 ± 26,229) and the BD had the lowest total annual healthcare cost ($18,312 ± 25,091). PAM-MH score was inversely correlated with healthcare costs and regression analysis showed a PAM-MH score × gender interaction. The strongest negative relationship between PAM and cost was for males. These analyses support the inverse association between PAM-MH and healthcare service utilization and cost.
Identifiants
pubmed: 33205314
doi: 10.1007/s11414-020-09731-3
pii: 10.1007/s11414-020-09731-3
pmc: PMC8275543
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
382-399Informations de copyright
© 2020. The Author(s).
Références
Schizophr Res. 2010 May;118(1-3):264-70
pubmed: 20185272
Am J Manag Care. 2010 May;16(5):370-7
pubmed: 20469957
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
Adm Policy Ment Health. 2010 Jul;37(4):327-33
pubmed: 19728074
Am Fam Physician. 2000 Sep 15;62(6):1343-53, 1357-8
pubmed: 11011863
Psychiatr Serv. 2009 Nov;60(11):1535-9
pubmed: 19880475
Neuron. 2000 Nov;28(2):335-41
pubmed: 11144343
J Gen Intern Med. 2012 May;27(5):520-6
pubmed: 22127797
Adm Policy Ment Health. 2008 Sep;35(5):370-8
pubmed: 18561020
Health Aff (Millwood). 2013 Feb;32(2):216-22
pubmed: 23381513
Pharmacoeconomics. 2004;22(6):363-73
pubmed: 15099122
Lancet. 2009 Aug 22;374(9690):635-45
pubmed: 19700006
Support Care Cancer. 2018 Apr;26(4):1221-1231
pubmed: 29098402
Curr Med Res Opin. 2010 Oct;26(10):2475-84
pubmed: 20825269
J Gen Intern Med. 2018 Dec;33(12):2106-2112
pubmed: 30291604
Pharmacoeconomics. 2001;19(5 Pt 1):483-95
pubmed: 11465308
Schizophr Bull. 2011 Sep;37 Suppl 2:S129-37
pubmed: 21860042
Psychiatr Serv. 2007 Sep;58(9):1219-21
pubmed: 17766569
Curr Med Res Opin. 2007 Oct;23(10):2305-12
pubmed: 17697454
Health Aff (Millwood). 2015 Mar;34(3):431-7
pubmed: 25732493
Ment Health Serv Res. 2001 Sep;3(3):141-53
pubmed: 11718206
Milbank Q. 1994;72(1):123-48
pubmed: 8164605
Psychiatry (Edgmont). 2005 Oct;2(10):47-55
pubmed: 21120090
Am J Psychiatry. 2005 Dec;162(12):2382-4
pubmed: 16330606